Cyclosiloxanes (D4 and D5) in Cosmetics: The Environmental Case Is Settled, the Human Health Case Is Not

Georden Jones, Founder, The Peer Review · Last updated: August 29, 2026

---

The Short Answer

Cyclosiloxanes, most commonly labeled cyclotetrasiloxane (D4) and cyclopentasiloxane (D5) on an ingredient list, are silicone-based compounds prized in cosmetics for the silky, lightweight feel they give to deodorants, hair products, and skin creams. This is a case where two different questions get different, defensible answers depending on which one you ask. The environmental question is close to settled: both D4 and D5 have been identified under EU chemical law as persistent and bioaccumulative, meaning they resist breaking down and build up in living tissue over time, and Canada’s own federal environmental assessment reached a similar conclusion, adding D4 to the official List of Toxic Substances under the Canadian Environmental Protection Act back in 2011 [1][2]. The human health question is a genuinely different story. Canada’s own scientists, in the same regulatory process that flagged D4 as an environmental concern, explicitly concluded it was not harmful to human health at current exposure levels, and toxicologists remain actively divided on whether D4’s effects in rodent reproductive studies translate to a real endocrine-disruption risk in people at all [2][3]. The European Union has moved further and faster than either Canada or the United States regardless of that disagreement: D4 has been banned outright in cosmetics since 2022, D5 has been capped at 0.1% in rinse-off products since 2020, and a further restriction adopted in 2024 extends the 0.1% cap to leave-on products for D5 and D6 starting in June 2026 [1][4]. Canada has imposed no cosmetic concentration restriction on any of the three, and the US EPA’s own chemical safety review of D4, requested by industry back in 2020, still has not been completed [1][5].

Evidence Rating: Mixed Signals. D4 and D5 being persistent, bioaccumulative environmental contaminants is General Consensus, formally recognized by both EU chemical regulators and Canada’s own federal environmental assessment [1][2]. Whether D4 acts as a genuine human endocrine disruptor at typical cosmetic exposure levels is Not Enough to Say. Toxicologists are actively split: some conclude the reproductive effects seen in rat studies are a rodent-specific mechanism with no clear human relevance, while others maintain that D4’s interaction with estrogen receptors supports classifying it as an endocrine-disrupting chemical [3][6]. D5 and D6’s human health profile carries even less concern than D4’s, with the EU’s own restriction framework treating them primarily as environmental rather than direct human health hazards [1][4]. This is a case where the strongest, most consistent evidence supports environmental caution, not a specific, settled claim about what these ingredients do to your body.

---

Table of Contents

• Identify: What Cyclosiloxanes Are, and Why D4 and D5 Are Treated Differently
• Where It Hides
• How It Affects You and Enters the Body
• Investigate: The Environmental Evidence vs. the Human Health Evidence
• What Canada Regulates, and What It Does Not
• What Canada, the US, and the EU Require
• Inform: What This Means for You
• Improve: How to Reduce Risk Without Overreacting
• What This Does Not Mean
• FAQ
• The Bottom Line
• References

---

Identify: What Cyclosiloxanes Are, and Why D4 and D5 Are Treated Differently

Cyclosiloxanes are a family of silicone-based ring compounds, distinct from the longer-chain silicone polymers like dimethicone that also show up frequently in cosmetics. The three most common in personal care products are cyclotetrasiloxane, four silicon-oxygen units in a ring and labeled D4, cyclopentasiloxane, five units, labeled D5, and cyclohexasiloxane, six units, labeled D6 [1][7]. Cosmetic chemists favor them because they evaporate cleanly off the skin after application, leaving behind a smooth, non-greasy finish without the tacky residue some other emollients produce, which is exactly why they show up so often in deodorants and antiperspirants specifically [7].

D4 and D5 are not treated as interchangeable by regulators, and the distinction matters for how worried to be about each one. D4 has been formally identified as a persistent, bioaccumulative, and toxic substance under EU chemical law, its most serious environmental hazard category, and separately carries an active, unresolved scientific debate about whether it also disrupts hormone signaling in mammals [1][3][6]. D5 and D6 are classified as very persistent and very bioaccumulative, a category focused specifically on environmental buildup rather than direct toxicity, and the human health evidence behind them is considerably thinner than what exists for D4 [1].

---

Where It Hides

Cyclosiloxanes turn up across a specific, identifiable set of personal care products where their evaporating, silky-feel properties are most valued [1][7]:

• Deodorants and antiperspirants. The single most common source, since D4 and D5 give these products a dry, non-tacky finish immediately after application.
• Hair conditioners, serums, and styling products. Used to add shine and reduce frizz without weighing hair down.
• Foundation, primer, and other liquid makeup. Contributes to the smooth, blurred-finish texture many silicone-based primers are known for.
• Skin creams and lotions. Used as a lightweight carrier that helps other ingredients spread evenly without feeling greasy.
• Sunscreen formulas. Sometimes used to improve the texture and application feel of mineral or chemical UV filters.

---

How It Affects You and Enters the Body

The exposure picture for cyclosiloxanes is genuinely different from most other Fine Print entries, because a meaningful share of the concern here is about what happens after the product leaves your body, not just what happens while it is on you [1][2][7]:

• Skin application and evaporation is the main direct human exposure route. Most D4 and D5 in a cosmetic formula evaporates off the skin within minutes to hours of application, meaning a portion of your exposure is inhaled as vapor from the product drying rather than absorbed through the skin itself [1][7].
• Dermal absorption of the remaining fraction is limited but real. Some cyclosiloxane does penetrate the skin before evaporating, which is the exposure route studied in the rodent reproductive toxicity research discussed in the next section [3].
• Down-the-drain release drives the environmental concern, not a direct human exposure pathway. Rinse-off products containing D4, D5, or D6 send these compounds into wastewater, where their resistance to breakdown allows them to persist and accumulate in aquatic sediment and wildlife, which is the specific hazard both the EU and Canada’s environmental assessments are built around [1][2].
• Inhalation from deodorant and antiperspirant application is a distinct, repeated daily route worth naming specifically, since these products are applied close to the face and underarms every day for most users, a higher-frequency exposure pattern than most other leave-on cosmetics [7].

---

Investigate: The Environmental Evidence vs. the Human Health Evidence

1. Environmental persistence and bioaccumulation (strong, consistent evidence across regulators). This is the part of the cyclosiloxane story where independent assessments genuinely agree. The EU’s own chemical safety agency classifies D4 as persistent, bioaccumulative, and toxic, and D5 and D6 as very persistent and very bioaccumulative, its two most serious long-term environmental hazard categories [1]. Canada’s federal environmental assessment reached a closely related conclusion for D4 specifically, adding it to the official List of Toxic Substances under the Canadian Environmental Protection Act in February 2011, based on its resistance to environmental breakdown and its tendency to accumulate in wildlife over time [2]. This agreement across two independent regulatory systems, using different assessment processes, is a meaningfully stronger evidence pattern than a single agency’s opinion.

2. D4 and human endocrine disruption (genuinely disputed). This is the part of the story where reasonable scientists disagree, not a case of industry denial versus consumer advocacy. A two-generation reproductive toxicity study in rats found that D4 vapor exposure delayed a specific hormone surge involved in the reproductive cycle, producing downstream effects on uterine and ovarian tissue at higher exposure levels [3]. The dispute is about what that finding means for humans. Some toxicologists who have reviewed the mechanism in depth conclude the effect relies on a reproductive pathway specific to rodents that does not have a clear human equivalent, and argue D4 should not be classified as a human endocrine disruptor on that basis [3][6]. Other reviewers point to laboratory evidence that D4 interacts directly with the estrogen receptor and argue this interaction supports classifying it as an endocrine-disrupting chemical regardless of how the rodent-specific reproductive pathway is interpreted [6]. Neither side is disputing the underlying laboratory data. They are disputing how to interpret its relevance to human risk, which is exactly the kind of mechanistic uncertainty that belongs in the “not enough to say” category rather than being resolved in either direction by a headline.

3. D5 and D6 human health evidence (weaker still, closer to Canada’s own conclusion). Canada’s federal assessment process, the same one that flagged D4 as environmentally toxic, specifically concluded D5 was not harmful to either human health or the environment on its own, a finding strong enough that Canada removed D5 from a proposed toxic substances list in February 2012 after further review [2]. This is a notably different outcome from the EU’s approach, which restricts D5 primarily on environmental persistence grounds under its very persistent, very bioaccumulative classification rather than a direct human toxicity finding [1].

---

What Canada Regulates, and What It Does Not

Canada’s regulatory posture on cyclosiloxanes is unusual compared to most ingredients covered on this site, because the country has taken clear, formal environmental action while declining to impose any cosmetic-specific restriction at all. D4 is listed on Schedule 1 of the Canadian Environmental Protection Act, the official toxic substances list, based on its environmental persistence and bioaccumulation, and Canada has implemented pollution-prevention planning requirements aimed at reducing D4 releases into wastewater from industrial sources [2]. At the same time, Canada’s own assessment explicitly found D4 was not harmful to human health at the exposure levels being evaluated, and D5 was found not harmful to either human health or the environment and was subsequently removed from consideration for the toxic substances list entirely [2].

The practical result is that Health Canada has never imposed a concentration limit on D4, D5, or D6 specifically for their use in cosmetic products, unlike the EU’s approach covered below. Canada’s regulatory attention here has gone toward environmental release from industrial and wastewater sources, not toward the finished personal care products sitting on a store shelf [2].

---

What Canada, the US, and the EU Require

Requirement	Canada	United States	European Union
D4 in cosmetics	No cosmetic-specific concentration restriction; listed as environmentally toxic under CEPA since 2011 [2]	No federal restriction; EPA’s TSCA risk evaluation, requested by industry in 2020, remains incomplete [1][5]	Banned outright in cosmetic products since January 1, 2022 [1][4]
D5 in cosmetics	No cosmetic-specific concentration restriction; found not harmful to human health or environment in Canada’s own assessment [2]	No federal restriction	Capped at 0.1% in rinse-off products since January 2020; expanding to 0.1% in leave-on products as well starting June 6, 2026 [1][4]
D6 in cosmetics	No cosmetic-specific concentration restriction	No federal restriction	Same expanding 0.1% cap as D5, effective June 6, 2026 [1][4]
Basis for restriction	Environmental persistence and bioaccumulation (CEPA Schedule 1) [2]	No formal basis established; review incomplete [5]	Persistent, bioaccumulative, and toxic (D4) or very persistent, very bioaccumulative (D5, D6) classification under REACH [1]

The pattern here inverts what shows up in many other Fine Print comparisons on this site. The EU has taken the most aggressive regulatory action of the three, but its own restriction framework is built primarily on environmental persistence classifications rather than a specific, confirmed human health hazard finding. Canada has done real environmental regulatory work, adding D4 to its toxic substances list back in 2011, but has stopped short of any cosmetic product restriction, consistent with its own conclusion that D4 does not present a human health hazard at current exposure levels. The US sits furthest behind on both fronts, with an EPA chemical safety review still incomplete six years after industry itself requested it.

---

Inform: What This Means for You

• The environmental case against D4 and D5 is the strongest, most consistently supported part of this story, confirmed independently by both the EU’s chemical safety framework and Canada’s federal environmental assessment [1][2].
• The human health case, specifically whether D4 disrupts hormone signaling in people, remains genuinely unresolved among toxicologists, not settled in either direction [3][6].
• Canada’s own scientists concluded D4 does not harm human health at current exposure levels, even while classifying it as environmentally toxic, which is why Canada regulates industrial release but not cosmetic formulas [2].
• The EU’s 2022 ban on D4 in cosmetics is real and already in effect, and its D5 and D6 restrictions are about to expand from rinse-off products only to leave-on products as well, starting June 2026 [1][4].
• The US federal government has taken no position at all, with the EPA’s own requested chemical safety review of D4 still unfinished as of 2026, six years after it began [1][5].

---

Improve: How to Reduce Risk Without Overreacting

1. If you want to align with the EU’s more precautionary environmental standard, check ingredient lists for cyclotetrasiloxane, cyclopentasiloxane, and cyclohexasiloxane specifically, since these are the INCI names that correspond to D4, D5, and D6 [1][7].
2. Prioritize this concern in rinse-off products you use daily, like conditioner or body wash, since down-the-drain release into wastewater is the strongest, most consistently supported hazard pathway here, not a direct human health effect [1][2].
3. Do not treat the D4 endocrine-disruption question as settled science in either direction, since credentialed toxicologists genuinely disagree on whether the rodent findings translate to human risk [3][6].
4. If you are pregnant or specifically concerned about hormone-related effects, avoiding D4 in leave-on products is a reasonable precaution given the unresolved mechanistic debate, even though Canada’s own assessment did not find a confirmed human health hazard [2][3].
5. Products formulated to comply with the EU’s 2022 D4 ban and 2020 D5 restriction are already meeting the strictest global standard on this ingredient family, which is a useful shortcut if you would rather not track the ingredient list yourself.

---

What This Does Not Mean

This is not a case for assuming every silicone-containing deodorant or conditioner is quietly disrupting your hormones, and it is not a case for dismissing the environmental concern because the human health question remains unresolved. The environmental evidence against D4 and D5 is genuinely strong and independently confirmed by two different regulatory systems using two different assessment processes, which is a meaningfully more solid evidence pattern than most single-agency findings covered elsewhere on this site. The human health question is a separate matter entirely, and Canada’s own federal scientists, working through the same process that flagged D4’s environmental harm, explicitly concluded it was not harmful to human health at current exposure levels. The active scientific disagreement over whether D4’s rodent reproductive effects translate to human endocrine disruption is a legitimate, ongoing debate among toxicologists, not a case of one side hiding evidence from the other. Holding these two conclusions at once, real and well-supported environmental persistence alongside a genuinely unresolved human health question, is the accurate picture, and it is exactly why the EU has moved to restrict these ingredients on environmental grounds while Canada has focused its regulatory attention on industrial release rather than the cosmetic products themselves.

---

FAQ

---

The Bottom Line

Cyclosiloxanes split cleanly into two different questions with two different levels of certainty. The environmental case is strong and independently confirmed: both the EU’s chemical safety framework and Canada’s own federal assessment classify D4 as persistent and bioaccumulative, and Canada added it to its official toxic substances list back in 2011 [1][2]. The human health case, particularly whether D4 disrupts hormone signaling in people, remains a genuine, active dispute among toxicologists rather than a settled hazard, and Canada’s own scientists concluded D4 was not harmful to human health at current exposure levels even as they flagged its environmental persistence [2][3][6]. The EU has moved furthest regardless, banning D4 in cosmetics outright since 2022 and expanding its D5 and D6 restrictions to leave-on products starting in June 2026, while the US federal government has not completed even its own requested chemical safety review six years after industry asked for one [1][4][5]. If the environmental persistence angle matters to you, check for cyclotetrasiloxane, cyclopentasiloxane, and cyclohexasiloxane on ingredient lists, especially in rinse-off products.

Stay curious, stay critical.
Georden

---

References

1. European Chemicals Agency. “Cyclosiloxanes,” Hot Topics.
2. Government of Canada. “Toxic Substances List: Siloxane D4.”
3. “A Two-Generation Reproductive Toxicity Study of Octamethylcyclotetrasiloxane (D4) in Rats Exposed by Whole-Body Vapor Inhalation.” PubMed.
4. Biorius. “D4, D5, D6 REACh Restrictions Published.”
5. US Environmental Protection Agency TSCA risk evaluation program, D4 chemical review status.
6. “A Mechanistic Evaluation of the Potential for Octamethylcyclotetrasiloxane to Produce Effects via Endocrine Modes of Action.” Critical Reviews in Toxicology.
7. Government of Canada. “Siloxanes Group,” Chemicals at a Glance.

---

Georden Jones is the founder of The Peer Review. Read the full story.